Free CME Summit on Myelodysplastic Syndromes
Improving MDS Outcomes From Diagnosis to Treatment: A Multidisciplinary Approach
There are many complexities associated with myelodysplastic syndromes (MDS) that a multispecialty team must address as a clinical-care unit. These complexities include obtaining adequate bone marrow specimens, identification and classification of MDS, the comorbidity rate of MDS patients, and the decision-making process for treatment. To address educational gaps associated with these complexities, ASH, the American Society for Clinical Pathology (ASCP), and the France Foundation have designed comprehensive MDS-directed educational summits that feature live events designed by world-class subject matter experts.
Participants of these summits will actively engage in multidisciplinary, interactive small-group activities, including case-based tumor board discussions and four break-out sessions on:
- Assessing low- or high-grade MDS
- Acquiring of morphologic mimics
- Applying the prognostic scoring system to cytogenetics
- Identifying the new role of molecular testing
Who should attend?
- Medical Oncologists
- Pathologists' Assistants
- Hematology and Oncology Nurse Practitioners
- Physician Assistants
- Medical Laboratory Scientists
Dates and Locations
Registration is free for these events.
October 18, 2017
Dallas Marriott Suites Medical/Market Center
November 8, 2017
Los Angeles, CA
The Westin Bonaventure Hotel & Suites
For more information on registration and accreditation or to view the schedule and program, please visit the summit website.
back to top